Delayed gadolinium enhanced MRI of cartilage (dGEMRIC) of the first carpometacarpal (1CMC) joint: a feasibility study  by Williams, A. et al.
Osteoarthritis and Cartilage (2008) 16, 530e532
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.joca.2007.11.002
International
Cartilage
Repair
SocietyShort communication
Delayed gadolinium enhanced MRI of cartilage (dGEMRIC)
of the ﬁrst carpometacarpal (1CMC) joint: a feasibility study1
A. Williams M.S.y, S. K. Shetty M.D.y, D. Burstein Ph.D.yx*, C. S. Day M.D.z
and C. McKenzie Ph.D.yx
yDepartment of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA
zDepartment of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA
xHarvard Medical School, Boston, MA, USAKey words: dGEMRIC, Carpometacarpal, MRI.Introduction and summary
The ﬁrst carpometacarpal (1CMC) joint, at the base of the
thumb, is a common site for symptomatic and radiographic
osteoarthritis (OA) among the elderly1e4. OA in the 1CMC
joint can be particularly debilitating because it is associated
with a decrease in pincer grip strength and limits activities
such as writing and handling small objects4. Currently, the
diagnosis and staging of 1CMC OA are based on physical
signs and symptoms and radiographic evidence of reactive
bone changes5. A deeper appreciation of OA etiology and
progression in the 1CMC joint is currently limited by a lack
of markers sensitive to early intraarticular degenerative
changes, particularly those that are radiographically
occult, that can be used to quantitatively assess disease sta-
tus and therapeutic efﬁcacy. The dGEMRIC (delayed gado-
linium enhanced magnetic resonance imaging [MRI] of
cartilage) technique has previously been used in the knee
and hip as a non-invasive method to evaluate one aspect
of cartilage biochemical status, that of the spatial distribution
of cartilage glycosaminoglycan (GAG) concentration6e10,
but has never been applied to the thin cartilage in the
hand. This study found dGEMRIC evaluation of the 1CMC
joint is technically feasible and demonstrates differences
between cartilage in asymptomatic and OA joints, potentially
providing an objective measure of disease progression and
a means for better understanding of biochemical changes
which might precede cartilage destruction.Methods, results and discussion
Nine subjects (ﬁve asymptomatic and four 1CMC OA)
were examined. Asymptomatic subjects (three women1This study was supported in part by Grant AR42773 from the
National Institutes of Health.
*Address correspondence and reprint requests to: Dr Deborah
Burstein, Beth Israel Deaconess Medical Center, HIM Building,
Room 148, #4 Blackfan Circle, Boston, MA 02115, USA.
Tel: 1-617-667-3349; Fax: 1-617-667-7021; E-mail: dburstei@
bidmc.harvard.edu
Received 25 July 2007; revision accepted 4 November 2007.
530and two men; mean age¼ 28 6 yrs) reported no current
or prior joint pain. OA subjects (three women and one
man; mean age¼ 54 6 yrs) were diagnosed based on
joint pain on palpation and/or radiographic evidence of
narrowed joint space or osteophytes including the following:
radiographically normal Eaton Stage I OA (n¼ 1), Eaton
Stage I OA with deQuervain’s tenosynovitis (n¼ 1); bilateral
early radiographic OA, Eaton stage II (n¼ 1); and radio-
graphic Eaton stage III OA (n¼ 1)11. The right hands of
asymptomatic subjects and the more severely affected
hands of OA subjects were imaged, except in one case
where both hands of an OA subject (bilateral Eaton stage II)
were imaged. All studies were approved by the institutional
review board, and all subjects gave their informed
consent.
dGEMRIC examinations were performed on all subjects12.
Volunteers received an IV injection of 0.2 mM/kg Magnevist
(Berlex Imaging, Wayne, NJ, USA). Immediately following
injection, subjects exercised the study hand by repetitively
squeezing and releasing a ball for 5 min. Volunteers were im-
aged with a 1.5 T GE Signa TwinSpeed MR imager (GE
Healthcare, Waukesha, WI, USA) using a body coil for trans-
mit and a commercially available receive only 1-inch surface
coil (eCoil, Medrad, Indianola, PA, USA) placed on the dorsal
surface of the thumb in receive mode. dGEMRIC images
were acquired 60 min following injection.
At each dGEMRIC acquisition, a single sagittal slice
(oriented to the thumb) was placed roughly in the center
of the carpometacarpal joint, and a series of inversion re-
coveryefast spin echo (IReFSE) images with a 6 cm ﬁeld
of view and 235 mm in-plane 1.5 mm thick resolution
were acquired. In order to achieve the high in-plane resolu-
tion, the ‘‘Zoom’’ gradient (40 mT/m max gradient strength
and 150 mT/m/ms slew rate) of the TwinSpeed MRI was
used for all imaging. Prior to reconstruction, images were
interpolated in k-space to a 512 matrix. The inversion recov-
ery image series was acquired with parameters: ﬁve inver-
sion times (Ti) ranging 50e1650 ms, 1767 ms repetition
time (TR, time between inversion pulses), 20 kHz receiver
bandwidth, echo train length of ﬁve, and two signal
averages. The T1 measurement time was 15 min.
Proton density FSE images of the same geometry were
acquired to provide visual guidance for manual segmentation
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Fig. 1. Examples of 1CMC dGEMRIC acquired 60 min after injection: (a) 28-yr-old asymptomatic woman; (b) 50-yr-old woman with painful OA,
Eaton Stage I; (c) 50-yr-old professional drummer with radiographic OA, Eaton Stage II. Both OA subjects have lower dGEMRIC indices over
the entire joint relative to the asymptomatic subject.
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est (ROIs) were drawn on the trapezial and metacarpal
surfaces of the 1CMC joint, and sub-regions were
drawn on the volar and dorsal aspects of the metacar-
pal surface. Volar aspect ROIs were deﬁned as full-
thickness cartilage comprising the volar 1/4e1/3 of the
metacarpal surface based on visual inspection; more
dorsal regions were deﬁned as all metacarpal cartilage
dorsal to the volar aspect ROI. T1 maps of the cartilage
regions were generated using custom coded software
(MRIMapper, MIT and Beth Israel Deaconess Medical
Center, 2006) for Matlab (The MathWorks, Natick, MA,
USA).
Examples of 1CMC dGEMRIC images from three individ-
uals acquired 60 min after injection are shown in Fig. 1. The
asymptomatic subject demonstrates higher and more
homogeneous dGEMRIC indices than are seen in the
Eaton stage I or Eaton stage II subjects.
Asymptomatic subjects demonstrated generally higher
metacarpal dGEMRIC indices (371 54 ms, n¼ 5) than
the OA cohort (284 48 ms, n¼ 5 hands from four OA sub-
jects). Trapezial surface dGEMRIC indices were also higher
for the asymptomatic group compared to OA subjects
(405 82 ms vs 308 69 ms).
Volar cartilage was absent in two of OA joints examined
and, therefore, was not included in a regional analysis. A
trend for lower dGEMRIC indices in the volar aspect of
the metacarpal surface than in more dorsal regions was
observed in both asymptomatics (n¼ 5, 329 83 ms vs
399 45 ms, volar vs dorsal) and in OA subjects (n¼ 3,
272 30 ms vs 308 99 ms, volar vs dorsal).
The results of the present study demonstrate the fea-
sibility of dGEMRIC evaluation of 1CMC joint cartilage
using commonly available hardware and imaging
sequences. dGEMRIC indices measured here were
shown to be in the same general range as dGEMRIC
values previously measured in the hip and knee7,8.
Moreover, dGEMRIC indices of subjects with 1CMC
OA were shown to be generally lower than asymptom-
atics, suggesting that the technique may be sensitive
to OA induced biochemical changes in 1CMC cartilage.
While cartilage thickness was not measured in the
current study, dGEMRIC may provide a complementary
tool to quantitative MRI measures for metacarpophalan-
geal cartilage volume13 and interphalangeal cartilage T2
mapping14.The choice of imaging sequence and parameters in this
work was constrained by the need to achieve 100 mm in-
plane resolution in order to image the thin cartilage with
adequate signal to noise ratio (SNR) for T1 quantiﬁcation
while using a 1-inch receive surface coil. Consequently,
dGEMRIC measurement of a single two-dimensional (2D)
section 1.5 mm thick required 15 min of acquisition-time.
In the future, scan-time may be reduced by employing
a coil with better SNR, thus eliminating the need for averag-
ing (i.e., two averages). Higher SNR may also permit the
use of three-dimensional (3D) techniques capable of prob-
ing the entire 1CMC joint in a single imaging session.
The 60-min delay between injection and dGEMRIC acqui-
sition used here differs from the 90e120 min delay commonly
used in the knee8,9, although 30e60 min post-contrast has
been shown to yield higher sensitivity to differences between
control and OA subjects in studies of the hip7,10. Further work
is needed to determine the optimal window for imaging the
1CMC joint.
Due to the difference in age between the control group
and OA subjects examined in this study (mean age
28 6 yrs vs 54 6 yrs, respectively), and in light of the
high frequency of asymptomatic radiographic degeneration
of the 1CMC joint in the general population over 50 yrs of
age1,3,4, it has yet to be determined if the dGEMRIC differ-
ence noted between the groups here is due to disease or
the result of the aging process. Bilateral dGEMRIC evalua-
tions of subjects with unilateral symptomatic 1CMC OA may
help to shed light on this issue.
A prior report of articular cartilage wear patterns of the
1CMC joint in cadaveric specimens noteda trend for cartilage
degeneration starting in the volar/radial quadrant of themeta-
carpal surface with subsequent dorsal and ulnar aspect
involvement in more advanced OA15. In the present pilot
study, dGEMRIC variations consistent with this trend were
observed. The volar aspect of the metacarpal surface dem-
onstrated lower dGEMRIC values than more dorsal regions.
In this work, dGEMRIC evaluation was limited to a single
1.5 mm section from the center of the joint, thus only a small
portion of each metacarpal surface was sampled. However,
given that volar regions sampled here tended to show rela-
tively low dGEMRIC indices and that volar cartilage was alto-
gether absent in two of the OA joints examined, these data
are compatible with prior reports and suggest that that low
dGEMRIC index reﬂects tissue in a degenerate biochemical
state that may also be more vulnerable to tissue thinning.
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